The booster dose of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral and clinical response and serological conversion predictors

Acta Oncol. 2023 Dec;62(12):1939-1941. doi: 10.1080/0284186X.2023.2254923. Epub 2023 Sep 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine* / adverse effects
  • COVID-19 / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans

Substances

  • BNT162 Vaccine